Affimed (AFMDQ) Earnings Date & Reports

Affimed NV is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AFMDQ is expected to report earnings to fall 32.86% to -23 cents per share on August 07

Q2'25

Est.

$-0.23

Q1'25

Beat

by $0.22

Q4'24

Missed

by $0.12

The last earnings report on May 21 showed earnings per share of -34 cents, beating the estimate of -56 cents. With 17.54K shares outstanding, the current market capitalization sits at 1.27M.

View a ticker or compare two or three

Compare

AFMDQ

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AFMDQ
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details